Financials
- Market Capitalization 21.37 M
- Employee 129
- Founded 1997
- CEO N/A
- Website www.cytosorbents.com
- Headquarter Delaware, United States
- FIGI BBG000C3P8V0
- Industry Medical Devices
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4445 | TELA TELA Bio, Inc. - Common stock | 0.70 USD | +7.69% | +6.06% | +1.45% | -60.23% | 31.43 M USD | ||
| 4473 | MODD Modular Medical, Inc. - common stock | 3.46 USD | -4.16% | -1.14% | +71.29% | +401.45% | 28.20 M USD | ||
| 4553 | LFWD Lifeward Ltd. - Ordinary Shares | 7.46 USD | +1.22% | +0.40% | +6.88% | +1307.55% | 21.13 M USD | ||
| 4561 | PMI Picard Medical, Inc. Common Stock | 8.76 USD | -3.74% | +95.54% | +93.81% | +81.37% | 20.49 M USD |
Frequently asked questions about Cytosorbents Corp.
What is the Cytosorbents Corp. stock price today?
The current price of Cytosorbents Corp. (CTSO) is 0.34. Over the past 24 hours, the stock has changed by 0.00%. Follow the CTSO chart for real-time price dynamics.
What is the stock ticker of Cytosorbents Corp.?
Cytosorbents Corp. trades under the ticker CTSO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cytosorbents Corp. stock going up?
CTSO has changed by -2.86% over the last week, -5.56% over the last month, and -63.44% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Cytosorbents Corp.?
Cytosorbents Corp. currently has a market capitalization of 21.37 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Cytosorbents Corp. earnings last quarter?
Last quarter, Cytosorbents Corp. reported earnings of -0.07 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Cytosorbents Corp. revenue for the last quarter?
Cytosorbents Corp. reported quarterly revenue of 9.63 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Cytosorbents Corp. net income for the last quarter?
Cytosorbents Corp. reported net income of -4.42 M for the last quarter. The previous quarter showed -5.13 M, which means net income changed by +13.88%.
How many employees does Cytosorbents Corp. have?
As of the latest available data, Cytosorbents Corp. has 129 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cytosorbents Corp. EBITDA?
Cytosorbents Corp. EBITDA is -2 M, and its EBITDA margin is -20.72%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cytosorbents Corp. stock?
You can buy Cytosorbents Corp. (CTSO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cytosorbents Corp. stock?
Investing in Cytosorbents Corp. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CTSO chart and related analysis on metatrader.com as part of your research.